vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.
SMITH & WESSON BRANDS, INC. is the larger business by last-quarter revenue ($124.7M vs $123.8M, roughly 1.0× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs 1.5%, a 1.8% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -3.9%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -4.8%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
NATR vs SWBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $124.7M |
| Net Profit | $4.1M | $1.9M |
| Gross Margin | 72.5% | 24.3% |
| Operating Margin | 4.3% | 3.3% |
| Net Margin | 3.3% | 1.5% |
| Revenue YoY | 4.7% | -3.9% |
| Net Profit YoY | 1379.4% | -53.6% |
| EPS (diluted) | $0.23 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $124.7M | ||
| Q3 25 | $128.3M | $85.1M | ||
| Q2 25 | $114.8M | $140.8M | ||
| Q1 25 | $113.2M | $115.9M | ||
| Q4 24 | $118.2M | $129.7M | ||
| Q3 24 | $114.6M | $88.3M | ||
| Q2 24 | $110.6M | $159.1M | ||
| Q1 24 | $111.0M | $137.5M |
| Q4 25 | $4.1M | $1.9M | ||
| Q3 25 | $5.3M | $-3.4M | ||
| Q2 25 | $5.3M | $8.6M | ||
| Q1 25 | $4.7M | $2.1M | ||
| Q4 24 | $-321.0K | $4.5M | ||
| Q3 24 | $4.3M | $-1.9M | ||
| Q2 24 | $1.3M | $27.9M | ||
| Q1 24 | $2.3M | $7.9M |
| Q4 25 | 72.5% | 24.3% | ||
| Q3 25 | 73.3% | 25.9% | ||
| Q2 25 | 71.7% | 28.8% | ||
| Q1 25 | 72.1% | 24.1% | ||
| Q4 24 | 72.0% | 26.6% | ||
| Q3 24 | 71.3% | 27.4% | ||
| Q2 24 | 71.4% | 35.5% | ||
| Q1 24 | 71.2% | 28.7% |
| Q4 25 | 4.3% | 3.3% | ||
| Q3 25 | 7.0% | -3.5% | ||
| Q2 25 | 3.7% | 9.3% | ||
| Q1 25 | 5.4% | 4.1% | ||
| Q4 24 | 3.8% | 5.8% | ||
| Q3 24 | 4.6% | -1.7% | ||
| Q2 24 | 5.1% | 17.4% | ||
| Q1 24 | 4.2% | 8.2% |
| Q4 25 | 3.3% | 1.5% | ||
| Q3 25 | 4.2% | -4.0% | ||
| Q2 25 | 4.6% | 6.1% | ||
| Q1 25 | 4.2% | 1.8% | ||
| Q4 24 | -0.3% | 3.5% | ||
| Q3 24 | 3.8% | -2.1% | ||
| Q2 24 | 1.2% | 17.5% | ||
| Q1 24 | 2.1% | 5.7% |
| Q4 25 | $0.23 | $0.04 | ||
| Q3 25 | $0.30 | $-0.08 | ||
| Q2 25 | $0.28 | $0.19 | ||
| Q1 25 | $0.25 | $0.05 | ||
| Q4 24 | $-0.02 | $0.10 | ||
| Q3 24 | $0.23 | $-0.04 | ||
| Q2 24 | $0.07 | $0.60 | ||
| Q1 24 | $0.12 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $22.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $363.2M |
| Total Assets | $261.1M | $548.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $22.4M | ||
| Q3 25 | $95.6M | $18.0M | ||
| Q2 25 | $81.3M | $25.2M | ||
| Q1 25 | $86.5M | $26.7M | ||
| Q4 24 | $84.7M | $39.1M | ||
| Q3 24 | $78.7M | $35.5M | ||
| Q2 24 | $68.7M | $60.8M | ||
| Q1 24 | $77.8M | $47.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $363.2M | ||
| Q3 25 | $166.7M | $364.4M | ||
| Q2 25 | $163.7M | $372.5M | ||
| Q1 25 | $167.1M | $366.9M | ||
| Q4 24 | $161.0M | $371.5M | ||
| Q3 24 | $162.6M | $380.0M | ||
| Q2 24 | $156.4M | $399.9M | ||
| Q1 24 | $159.7M | $376.4M |
| Q4 25 | $261.1M | $548.6M | ||
| Q3 25 | $264.8M | $554.6M | ||
| Q2 25 | $254.9M | $559.6M | ||
| Q1 25 | $252.7M | $578.9M | ||
| Q4 24 | $240.9M | $587.4M | ||
| Q3 24 | $245.3M | $571.3M | ||
| Q2 24 | $235.8M | $577.4M | ||
| Q1 24 | $247.3M | $570.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $27.3M |
| Free Cash FlowOCF − Capex | $7.6M | $16.3M |
| FCF MarginFCF / Revenue | 6.1% | 13.1% |
| Capex IntensityCapex / Revenue | 1.9% | 8.8% |
| Cash ConversionOCF / Net Profit | 2.41× | 14.22× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $21.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $27.3M | ||
| Q3 25 | $18.5M | $-8.1M | ||
| Q2 25 | $4.3M | $40.8M | ||
| Q1 25 | $2.6M | $-9.8M | ||
| Q4 24 | $12.2M | $-7.4M | ||
| Q3 24 | $9.6M | $-30.8M | ||
| Q2 24 | $1.3M | $43.7M | ||
| Q1 24 | $2.2M | $25.2M |
| Q4 25 | $7.6M | $16.3M | ||
| Q3 25 | $16.8M | $-12.4M | ||
| Q2 25 | $3.0M | $33.5M | ||
| Q1 25 | $1.5M | $-16.1M | ||
| Q4 24 | $10.0M | $-10.7M | ||
| Q3 24 | $7.9M | $-35.5M | ||
| Q2 24 | $-2.0M | $38.2M | ||
| Q1 24 | $-1.5M | $7.0M |
| Q4 25 | 6.1% | 13.1% | ||
| Q3 25 | 13.1% | -14.6% | ||
| Q2 25 | 2.6% | 23.8% | ||
| Q1 25 | 1.3% | -13.9% | ||
| Q4 24 | 8.5% | -8.3% | ||
| Q3 24 | 6.9% | -40.2% | ||
| Q2 24 | -1.9% | 24.0% | ||
| Q1 24 | -1.4% | 5.1% |
| Q4 25 | 1.9% | 8.8% | ||
| Q3 25 | 1.3% | 5.0% | ||
| Q2 25 | 1.2% | 5.2% | ||
| Q1 25 | 1.0% | 5.4% | ||
| Q4 24 | 1.9% | 2.5% | ||
| Q3 24 | 1.5% | 5.3% | ||
| Q2 24 | 3.0% | 3.5% | ||
| Q1 24 | 3.3% | 13.2% |
| Q4 25 | 2.41× | 14.22× | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | 4.73× | ||
| Q1 25 | 0.55× | -4.68× | ||
| Q4 24 | — | -1.63× | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | 1.57× | ||
| Q1 24 | 0.94× | 3.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
SWBI
Segment breakdown not available.
